McKesson Corporation announced a significant strategic investment of USD 1.4 billion to acquire a minority interest in Option Care Health, a move detailed in an agreement dated October 6, 2026. This transaction values the healthcare services provider at approximately USD 5.8 billion and establishes a joint ownership structure where CD&R will hold roughly 51% of Option Care Health while McKesson retains approximately 49%. The deal is structured to allow Option Care Health to remain an independent entity led by its existing management team, signaling McKesson's continued expansion into the healthcare services sector. The corporate development is expected to close in the first half of calendar year 2027, pending customary closing conditions such as stockholder and regulatory approvals. This acquisition represents a major capital allocation decision for McKesson, aiming to strengthen its position in the home health and hospice care market. The company confirmed the agreement through its investor relations channel, highlighting the strategic importance of this partnership. Separately, McKesson stock was trading at EUR 896.00 during weekend sessions on October 18, 2026, according to data from Lang & Schwarz. The exchange displayed a bid of EUR 894.20 and an ask of EUR 897.80 at the time of reporting. This weekend trading activity reflects market interest in the stock outside of standard business hours, though the primary news driver remains the substantial investment in Option Care Health.